Introduction Cerebrovascular disease (CVD) is a concomitant disorder commonly found among cardiac surgery patients, and appears to be on the rise. For […]
A high dose of TA does not reduce incidence of blood product transfusion up to day 7, but is more effective than a low dose to decrease transfusion needs, blood loss, and repeat surgery.